Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Mitigating Cardiovascular Dysfunction Across the Cancer Continuum

Nonniekaye M. Shelburne
Marilyn J. Hammer
ONF 2018, 45(1), 15-17 DOI: 10.1188/18.ONF.15-17

The mechanisms and outcomes of cancer treatment–related cardiovascular dysfunction are complex and influenced by cardiotoxic treatment exposure, preexisting heart disease, and lifestyle factors. Establishing and implementing evidence to prevent, detect, and manage cancer treatment–related cardiotoxicity requires engagement by the nursing science community.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or